Advice
Following an abbreviated submission
desmopressin 240 micrograms oral lyophilisate (DesmoMelt®) is accepted for use in NHS Scotland for the treatment of primary nocturnal enuresis.
In patients for whom desmopressin oral lyophilisate is an appropriate choice of therapy, it offers a higher dose formulation at an equivalent cost to existing formulations.
Download detailed advice26KB (PDF)
Medicine details
- Medicine name:
- desmopressin 240 micrograms oral lyophilisate (Desmomelt)
- SMC ID:
- 357/07
- Indication:
- Primary nocturnal enuresis
- Pharmaceutical company
- Ferring Pharmaceuticals Ltd
- BNF chapter
- Endocrine system
- Submission type
- Abbreviated
- Status
- Accepted
- Date advice published
- 07 May 2007